World CDx 2026 has ended. This guide stays up as the record of who was there. Next: World CDx 2027, Aug 30 – Sep 2, 2027 in Boston

Biovica at World CDx 2026

Oct 5–8, 2026 Boston, MA ~900 attendees Website

Biovica takes part in 1 session at World CDx 2026 in Boston. Its program centers on blood biomarkers that show how a cancer drug is acting in the body. With BioTheryx, it makes the case for tracking thymidine kinase activity over time to guide dosing beyond the maximum tolerated dose.

OrganizationWorld CDx 2026 Attendance
Biovica
Uppsala, Sweden
◇Program Partner
biovica.com
Diagnostics & testing labsProgram Partner
Makes DiviTum TKa, an FDA-cleared blood test measuring thymidine kinase activity to track tumor proliferation, and runs it for oncology drug trials.
Talk
Thu Oct 8
11:50am
Beyond Maximum Tolerated Dose: Using a Dynamic Pharmacodynamic Biomarker, TKa, for Oncology Drug Development
with BioTheryx
Biomarker discovery & translation

Explore the full World CDx 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Boston. Leave your work email and we’ll be in touch.

Privacy

Download the full World CDx 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Biovica

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by World CDx or its organizers. Submit a correction